These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9336438)

  • 1. Expression of apoptosis-related Fas antigen and in vitro apoptosis of lymphocyte subsets from patients with primary Sjögren's syndrome: comment on the article by Lorenz et al.
    Zeher M; Gyimesi E; Szodoray P; Szondy Z
    Arthritis Rheum; 1997 Oct; 40(10):1912. PubMed ID: 9336438
    [No Abstract]   [Full Text] [Related]  

  • 2. Apoptosis of CD4+ T cells in Sjögren's syndrome: comment on the article by Zeher et al.
    Kazkaz H
    Arthritis Rheum; 2000 May; 43(5):1187-8. PubMed ID: 10817578
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunopathology of Gougerot-Sjogren syndrome].
    Youinou P; Mariette X
    Rev Prat; 2001 Jan; 51(2):165-70. PubMed ID: 11252942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome.
    Ichikawa Y; Arimori K; Yoshida M; Horiki T; Hoshina Y; Morita K; Uchiyama M; Shimizu H; Moriuchi J; Takaya M
    Clin Exp Rheumatol; 1995; 13(3):307-13. PubMed ID: 7554556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome.
    Nakamura H; Horai Y; Shimizu T; Kawakami A
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential localization of CD8+ alpha E beta 7+ T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome.
    Fujihara T; Fujita H; Tsubota K; Saito K; Tsuzaka K; Abe T; Takeuchi T
    J Immunol; 1999 Aug; 163(4):2226-35. PubMed ID: 10438965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome].
    Matsumura R; Umemiya K; Kagami M; Tomioka H; Tanabe E; Sugiyama T; Sueishi M
    Nihon Rinsho; 1995 Oct; 53(10):2446-50. PubMed ID: 8531353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanisms of cellular activation and tissue destruction in Sjögren's syndrome.
    Saito I
    Int Ophthalmol Clin; 1994; 34(1):137-43. PubMed ID: 8169067
    [No Abstract]   [Full Text] [Related]  

  • 9. Sjögren's syndrome. Autoimmune epithelitis.
    Tapinos NI; Polihronis M; Tzioufas AG; Moutsopoulos HM
    Adv Exp Med Biol; 1999; 455():127-34. PubMed ID: 10599333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome.
    Humphreys-Beher MG; Peck AB; Dang H; Talal N
    Clin Exp Immunol; 1999 Jun; 116(3):383-7. PubMed ID: 10361223
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of B cells and B cell clonality in Sjögren's syndrome.
    Youinou P; Devauchelle-Pensec V; Pers JO
    Arthritis Rheum; 2010 Sep; 62(9):2605-10. PubMed ID: 20496425
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphocyte subsets in labial salivary gland of Sjogren's syndrome].
    Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):83-8. PubMed ID: 8242827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistopathology of Sjögren's syndrome.
    Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
    Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
    Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
    J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjögren's syndrome patients with enlarged exocrine glands.
    Tsubota K; Fujita H; Tadano K; Onoda N; Tsuzaka K; Takeuchi T
    Clin Exp Immunol; 2002 Jul; 129(1):177-82. PubMed ID: 12100038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al.
    Voulgarelis M; Tzioufas AG; Moutsopoulos HM
    Arthritis Rheum; 2001 Feb; 44(2):490. PubMed ID: 11229485
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sjögren's syndrome. New diagnostic aspects].
    Haga HJ; Rygh T; Jacobsen H; Johannessen AC; Mjanger O; Jonsson R
    Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2197-200. PubMed ID: 9235711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD30 in primary Sjögren's syndrome.
    Gerli R; Caligaris-Cappio F; Bistoni O; Bertero MT; Giacomelli R; Falini B
    Clin Exp Rheumatol; 1999; 17(3):389-90. PubMed ID: 10410280
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
    Ping L; Ogawa N; Sugai S
    Arthritis Rheum; 2005 Feb; 52(2):573-81. PubMed ID: 15692983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjögren's syndrome.
    Shearn MA
    Major Probl Intern Med; 1971; 2():1-262. PubMed ID: 4949970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.